Articles tagged "Fungal infection"

2020 American Transplant Congress
Invasive Aspergillosis in Lung Transplant Recipients with Aspergillus Colonization Beyond One Year after Transplant
S. Davoudi, A. Pérez-Cortés Villalobos, T. Martinu, J. Tikkanen, D. Kumar, A. Humar, L. G. Singer, S. Keshavjee, S. Husain
University Health Network, Toronto, ON, Canada
*Purpose: Antifungal prophylaxis is recommended for Aspergillus colonization within a year in lung transplant recipients (LTRs) to prevent invasive aspergillosis (IA). However, the rate of…
2020 American Transplant Congress
Characteristics of Kidney Transplant Patients Diagnosed with Histoplasmosis
C. Miles, J. Hall, S. Westphal, E. Langewisch
University of Nebraska Medical Center, Omaha, NE
*Purpose: Histoplasmosis is responsible for the greatest number of hospitalizations and deaths due to endemic mycoses in the United States. Although lying near the western…
2020 American Transplant Congress
Cryptococcosis In Kidney Transplant Recipients: A Multicenter Retrospective Case-Control Study
L. Tardieu¹, O. Lortholary², F. Lanternier², A. Scemla³, C. Rafat¹
¹Urgences Néphrologiques et Transplantation Rénale, Hôpital Tenon, APHP, Paris, France, ²Service de Maladies Infectieuses et Tropicales – Centre d’Infectiologie Necker-Pasteur, Hôpital Necker, APHP, Paris, France, ³Service de Transplantation Rénale, Hôpital Necker, APHP, Paris, France
*Purpose: Cryptococcosis is the third most common invasive fungal infection in organ transplant recipients.The clinical approach and prognosis has been previously investigated in the setting…
2020 American Transplant Congress
Epidemiology of Invasive Fungal Infections in Heart Transplant Recipients
A. Couture-Cossette¹, A. Puing¹, A. Multani², O. Quintero¹, A. K. Subramanian¹, E. Henricksen³, R. Lee¹, Y. Moayedi⁴, K. Khush⁵, J. J. Teuteberg⁵, D. Y. Ho¹
¹Department of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, ²Department of Infectious Diseases, UCLA, Stanford, CA, ³Pharmacy, Stanford Healthtcare, Stanford, CA, ⁴Department of Cardiology, UHN, Toronto, ON, Canada, ⁵Division of Cardiology, Department of Medicine, Stanford University, Stanford, CA
*Purpose: The incidence and epidemiology of invasive fungal infections (IFI) after heart transplantation (HTx) are influenced by changes in environmental exposures, immunosuppression, and prophylaxis practices.…
2020 American Transplant Congress
Once Weekly Fluconazole is Effective for the Prevention of Oral Candidiasis in Kidney Transplant Recipients
J. Lockridge, D. Roberts, K. Spence, M. Stack, S. Rehman, A. Olyaei
OHSU, Portland, OR
*Purpose: Oropharyngeal candidiasis is an infection prevalent in renal transplant recipients, with significant concerns for invasive endoscopic workup and development into invasive fungal infections. While…
2020 American Transplant Congress
Correlation of CMV and EBV DNAemia in the Development of Invasive Fungal Disease among Pediatric Intestinal and Liver Transplant Recipients
B. M. Chatani¹, J. Garcia², T. Beduschi³, A. Tekin³, R. Vianna³, I. A. Gonzalez¹
¹Pediatric Infectious Disease, University of Miami Miller School of Medicine, Miami, FL, ²Pediatric Gastroenterology, University of Miami Miller School of Medicine, Miami, FL, ³Miami Transplant Institute, Miami, FL
*Purpose: Invasive fungal disease (IFD) among pediatric solid organ transplant recipients is a relatively rare event, however often results in death. There are many factors…
2020 American Transplant Congress
Voriconazole Associated Adverse Drug Events and Drug Monitoring in Lung Transplant Recipients
C. Y. Luo¹, R. G. Nador², R. D. Levy², J. Yee², L. Wei², N. Partovi¹
¹Vancouver General Hospital, Vancouver, BC, Canada, ²University of British Columbia, Vancouver, BC, Canada
*Purpose: Voriconazole is the drug of choice for prophylaxis and treatment of Aspergillus infection in lung transplant ( LTx) recipients. Voriconazole has a narrow therapeutic…
2020 American Transplant Congress
Evaluation of SUBA-Itraconazole Use in Lung Transplant Recipients
J. G. Youssef¹, C. Ahmed¹, B. J. Pierce², C. Pham², F. Ye¹, K. Tatum¹, S. Yau¹, A. Goodarzi¹, H. J. Huang¹
¹Department of Medicine, Houston Methodist Hospital, Houston, TX, ²Department of Pharmacy, Houston Methodist Hospital, Houston, TX
*Purpose: Itraconazole (IT) is commonly used after lung transplant for fungal prophylaxis, particularly in those with a history of skin cancer, concern for Histoplasmosis infection,…
2020 American Transplant Congress
Alternate Triazole Therapy for Breakthrough Invasive Fungal Disease in Lung Transplant Recipients on Triazole Prophylaxis
A. Abbas, H. Hassouna, F. Marco Canosa, K. D. Brizendine
Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Invasive fungal diseases (IFD) are a leading cause of infection related morbidity and mortality in lung transplant (LT) recipients. Data regarding outcomes of breakthrough…
2020 American Transplant Congress
Epidemiology of Invasive Candidiasis in Lung Transplant Recipients at a Large Transplant Center
F. J. Marco Canosa¹, J. A. Morillas¹, H. Hassouna², K. Brizendine¹
¹Infectious Disease Department, Cleveland Clinic Foundation, Cleveland, OH, ²Division of Infectious Disease, Spectrum Health Medical Group, Grand Rapids, MI
*Purpose: Invasive candidiasis (IC) represents the most common fungal infection in lung transplant recipients (LTR) early post-transplant. Universal antifungal prophylaxis is frequently employed, which may…